retatrutide type 2 diabetes phase 2 results 2024 2025 UK 2026: 3 Retatrutide hits 28% weight loss

The GLP-1 gum option is also a nice alternative medication modality for those patients who might not be interested in injections

Sustained adherence represents a major advantage: according to research from Northwestern Medicine, 50-75% of people who start taking standard-dose GLP-1 medications stop using them within a year

For eligible patients with severe obesity, bariatric surgery may be considered as per NICE guidelines

Heres Dr

These findings reinforce the role of metabolic homeostasis in neurovascular health and support the inclusion of dietary counseling in individualized migraine care strategies

That is your ideal injection day